China Medical System Holdings Limited

Symbol: CHSYF

PNK

0.9313

USD

Market price today

  • 6.8624

    P/E Ratio

  • 0.0111

    PEG Ratio

  • 2.28B

    MRK Cap

  • 0.01%

    DIV Yield

China Medical System Holdings Limited (CHSYF) Financial Statements

On the chart you can see the default numbers in dynamics for China Medical System Holdings Limited (CHSYF). Companys revenue shows the average of 3815.968 M which is 0.212 % gowth. The average gross profit for the whole period is 2652.834 M which is 0.217 %. The average gross profit ratio is 0.653 %. The net income growth for the company last year performance is -0.263 % which equals 0.312 % % on average for the whole company history.,

Balance Sheet

Diving into the fiscal trajectory of China Medical System Holdings Limited, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of -0.001. In the realm of current assets, CHSYF clocks in at 8794.435 in the reporting currency. A significant portion of these assets, precisely 6143.316, is held in cash and short-term investments. This segment shows a change of 0.047% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 1782.618, if any, in the reporting currency. This indicates a difference of -3.670% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 16.671 in the reporting currency. This figure signifies a year_over_year change of -0.282%. Shareholder value, as depicted by the total shareholder equity, is valued at 15520.208 in the reporting currency. The year over year change in this aspect is 0.064%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 1735.865, with an inventory valuation of 637.64, and goodwill valued at 1547.9, if any. The total intangible assets, if present, are valued at 2246.09.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006

balance-sheet.row.cash-and-short-term-investments

23343.586143.35867.74363.6
2672.3
1367.7
815.1
855.6
482.5
508.5
243.5
485
668.9
863.4
919
223.9
144.4
128.6
69.8

balance-sheet.row.short-term-investments

6185.671832.31491.3977.9
3.9
2.7
-16.1
-12
0
279.2
0
-0.8
0
-29.1
0.3
0.2
0
0
0

balance-sheet.row.net-receivables

8038.051735.92039.72169.2
1701.2
1568.7
1710.1
1462.7
1492.1
969.6
733.3
538.7
0
458.3
331
0
0
0
0

balance-sheet.row.inventory

2321.75637.6477.2472.6
381.2
407.1
434.7
460.4
509
385.2
189.5
166.1
96.7
132.2
106
75.5
40.6
78
13.1

balance-sheet.row.other-current-assets

7909.022109.91936.11352.2
227.7
211.6
154.7
180.9
1067.4
495.3
379.4
769.4
0
1.2
1
0
0
0
0

balance-sheet.row.total-current-assets

35426.738794.48829.47379.7
4978.5
3552.3
3146.4
2959.6
3550.9
2114.5
1545.6
1951.3
1809.2
1455.1
1357
526.6
375.3
348.9
170.9

balance-sheet.row.property-plant-equipment-net

1955.04473.7495.5544.9
531.7
863
635.2
610.1
565.7
453.6
395.1
374.2
178.2
48.5
21.8
24.4
37.3
36.1
35.1

balance-sheet.row.goodwill

6485.241547.916661691.2
1214.5
1384.5
1384.5
1384.5
1384.5
1384.5
1184.6
1095.4
1115
1122.7
2.5
2.6
4
4.2
0

balance-sheet.row.intangible-assets

11939.352246.13351.83006.2
2868.6
2459.1
2554.1
2720.3
2885.6
1087.6
440.9
242.5
219.9
212.6
35.6
44.1
51.7
4.5
0

balance-sheet.row.goodwill-and-intangible-assets

18424.637945017.84697.4
4083.1
3843.7
3938.6
4104.9
4270.1
2472.2
1625.5
1337.9
1334.9
1335.3
38.1
46.7
55.7
8.7
0

balance-sheet.row.long-term-investments

7584.181782.61850.52109.9
3051.4
2857.1
2748.9
2447.4
1363.4
1321.8
1308.5
130
0
37.3
9.9
10.4
0
0
0

balance-sheet.row.tax-assets

171.3540.43936.3
21.8
20.3
20.7
26.9
30.5
24.9
19.4
19.3
18.5
29.5
29.4
9.8
7.3
3.1
1.7

balance-sheet.row.other-non-current-assets

7292.622845.71521.31039.8
34.6
34.6
16.7
0
11
10.6
11.2
-0.8
109.5
74.4
24.3
2
5.5
4.5
2.9

balance-sheet.row.total-non-current-assets

35427.88936.48924.28428.2
7722.5
7618.7
7360.1
7189.3
6240.7
4283.1
3359.7
1860.7
1641.1
1525
123.4
93.2
105.7
52.4
39.7

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

70854.5217730.817753.515807.9
12701.1
11171
10506.5
10148.8
9791.6
6397.6
4905.3
3812
3450.3
2980.1
1480.4
619.8
481
401.4
210.6

balance-sheet.row.account-payables

698.58141.7178145.9
134.8
44
106.1
130
137.6
95.6
79.2
67.5
60.2
178.6
54.7
81.3
67.8
94.4
35.8

balance-sheet.row.short-term-debt

6164.631285.11799.11120.7
7.3
703.3
25
65
1612.4
463.9
484.2
312.2
404.8
251.4
28.3
112.8
0
0
29.2

balance-sheet.row.tax-payables

1584.26317389.1343.3
359
515
180.6
106
136.6
69.6
65.9
39.3
26
25.7
18
8.4
5.5
1.3
3.5

balance-sheet.row.long-term-debt-total

74.9616.713.5591.6
592.9
10.5
1440.2
2040
0
0
0
0
0
0
0
0
0
0
0

Deferred Revenue Non Current

-58.76-1090163.7
5.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

479.4---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

681.26112
2.9
10.7
8.8
8.8
1096.4
13.6
5.5
5.7
5.1
37
26.2
9.4
5.6
1.3
43.6

balance-sheet.row.total-non-current-liabilities

714.19125.6139.4879.6
686.4
107.1
1551.5
2162.4
127.6
141.9
125.8
50.1
52.2
54.7
44.8
48.2
47.9
0
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

134.2832.129.334.7
12.9
19.9
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

10571.62174.43016.52960.9
1598.4
1654.8
2102.4
2820.6
3523.8
1045.1
914.4
637.2
635.4
521.6
154
251.6
121.3
95.7
108.6

balance-sheet.row.preferred-stock

601.22287.4112.735.6
42.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

335.99848484.2
84.6
85
85
85.2
85.2
85.2
83
73.2
75.4
50.6
37.9
32.4
32.2
34.5
0

balance-sheet.row.retained-earnings

50802.221342612512.210550.1
8687.5
6320.5
5167.6
4153.2
3203.3
2405.2
2129.8
1375.2
0
0
0
123.7
61.4
21.5
-0.4

balance-sheet.row.accumulated-other-comprehensive-income-loss

-601.22-287.4-112.7-35.6
-42.9
5.1
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

8787.692010.31992.92118.2
2262
3062.2
3103.2
3036.3
2920.9
2805.6
1778
1713.5
2723
2391.8
1288.5
210.8
266.6
250.8
103.4

balance-sheet.row.total-stockholders-equity

59925.915520.214589.112752.4
11034.1
9472.9
8355.8
7274.7
6209.4
5296
3990.8
3161.8
2798.3
2442.4
1326.5
366.9
360.2
306.8
103.1

balance-sheet.row.total-liabilities-and-stockholders-equity

70854.5217730.817753.515807.9
12701.1
11171
10506.5
10148.8
9791.6
6397.6
4905.3
3812
3450.3
2980.1
1480.4
619.8
481
401.4
210.6

balance-sheet.row.minority-interest

357.0336.214894.5
68.6
43.3
48.3
53.6
58.4
56.5
0
13
16.6
16.1
0
1.4
-0.5
-1.1
-1.1

balance-sheet.row.total-equity

60282.9315556.414737.112847
11102.7
9516.1
8404.1
7328.3
6267.8
5352.5
3990.8
3174.8
2814.9
2458.5
1326.5
368.3
359.8
305.7
102

balance-sheet.row.total-liabilities-and-total-equity

70854.52---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

13769.853614.93341.93087.8
3055.3
2859.9
2732.7
2435.4
1363.4
1321.8
1308.5
129.2
109.5
8.2
10.1
10.6
3.7
2.6
0.9

balance-sheet.row.total-debt

6239.591301.71812.61712.3
600.2
713.8
1465.2
2105
1612.4
463.9
484.2
312.2
404.8
251.4
28.3
112.8
0
0
29.2

balance-sheet.row.net-debt

-10918.33-3009.3-2563.7-1673.4
-2068.3
-651.2
650.1
1249.4
1129.9
-44.6
240.7
-172.8
-264.1
-612.1
-890.5
-110.9
-144.4
-128.6
-40.6

Cash Flow Statement

The financial landscape of China Medical System Holdings Limited has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -0.279. The company recently extended its share capital by issuing 0, marking a difference of 0.000 compared to the previous year. The company's investing activities resulted in net cash usage, amounting to -442276000.000 in the reporting currency. This is a shift of -0.625 from the previous year. In the same period, the company recorded 229.56, 356.98, and -1786.73, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated -1360.36 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as -117.3, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006

cash-flows.row.net-income

8302873.83762.83456.6
2816.1
2487.7
2006.4
1808.4
1500.4
1064.1
1129.5
671.2
589.7
427.9
229.7
183.9
133.3
75.6
42

cash-flows.row.depreciation-and-amortization

63.47229.6227.2219.8
208.3
204.1
199
196.4
175.9
77.8
42.4
35.8
32.5
26.1
10.4
13.7
10.7
5.1
3.8

cash-flows.row.deferred-income-tax

0-467.4-489.2-548.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-11.1

cash-flows.row.stock-based-compensation

0-35.918.717.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
19.8

cash-flows.row.change-in-working-capital

0390.1-596.1
88.4
156.2
-377.3
133.2
-561
-424
-34.4
-320.4
-112.4
-18.6
-152.7
-58.2
-49.3
-38.2
3.6

cash-flows.row.account-receivables

0410.6163.9-367.9
-132.8
148.6
-230.9
192
-519.1
-278.4
-32.1
-282.2
0
0
0
0
0
0
0

cash-flows.row.inventory

0-235.88.2-90.9
25.8
24.7
-51.3
45.7
-126.8
-185
-26.2
-62.7
24.9
-9.7
-31.8
-35.7
36.5
-65.6
-1

cash-flows.row.account-payables

0-410.6-163.9367.9
132.8
-148.6
230.9
-192
519.1
278.4
32.1
282.2
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0238.781.9-505.2
62.5
131.6
-326.1
-104.5
84.9
39.4
23.9
24.4
-137.3
-8.8
-120.9
-22.5
-85.8
27.4
4.6

cash-flows.row.other-non-cash-items

145.19-100.2-56.4-55.5
-420.8
-292.9
-73.5
-66.2
-47.4
-103.3
-294.3
-58.7
-74.2
-41.1
-13.2
-33.2
-25.3
5.6
4.2

cash-flows.row.net-cash-provided-by-operating-activities

911.72000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-119.26-318-524.9-184.8
-341.4
-340.5
-62
-76.6
-1073.8
-580.6
-261.5
-144.6
-68.6
-86.7
-24.9
-1.9
-7.6
-5.8
-8.8

cash-flows.row.acquisitions-net

-0.52-123.6-298.8-563.9
0
-16.1
0
-1000
0
-229.4
-773.5
-78.1
0
-313.7
0
-3
0
-3.9
0

cash-flows.row.purchases-of-investments

-172.32-378-459.3-868.5
-156.9
-42.5
-231
-26.3
0
0
-154.6
0
-85.1
-241.9
0
0
0
-5.6
0

cash-flows.row.sales-maturities-of-investments

3.2520.33-61.3
0
-211.9
0
0
0
0
-155
0
0
29.2
87
0
1.3
0
0

cash-flows.row.other-investing-activites

-5.15357101.8159
144.5
301.6
53.2
748.8
-387.6
-42.4
408.4
52.6
-176.9
-62.9
4.7
-108.5
-5.6
1.8
39.2

cash-flows.row.net-cash-used-for-investing-activites

-294-442.3-1178.2-1519.5
-353.8
-309.4
-239.7
-354.1
-1461.3
-852.5
-936.2
-170.1
-330.7
-676
66.8
-113.5
-11.9
-13.6
30.4

cash-flows.row.debt-repayment

-88.09-1786.7-14280
-696.9
-801.6
-717.9
-3950.4
-1729.1
-619.8
-561.3
-399.4
-520.3
-55.2
-109.6
0
0
-94.3
-25

cash-flows.row.common-stock-issued

-2.4101320.60
593.3
0
-45
0
0
678.8
0
0
0
10
822.6
3.1
0
146
0

cash-flows.row.common-stock-repurchased

-230-48.4-151.5
-87
0
-53
0
0
536.4
0
0
0
0
-32.3
0
0
0
0

cash-flows.row.dividends-paid

-370.76-1360.4-1276.2-1154.8
-834.1
-822.8
-728.5
-611.1
-462.9
-369.6
-291
-235.9
-177.6
-159.4
-31.4
-64.7
-48.3
0
0

cash-flows.row.other-financing-activites

-10.46-117.332.11048
-9.8
-70.8
-9.8
3216.4
2836.2
-6.1
702.4
296
646
245.4
-5.1
34.1
-0.9
-29.3
-34.4

cash-flows.row.net-cash-used-provided-by-financing-activities

-487.05-2125-1399.9-258.4
-1034.6
-1695.1
-1554.3
-1345.1
644.2
219.7
-149.9
-339.2
-51.9
40.9
644.2
-27.5
-49.3
22.4
-59.4

cash-flows.row.effect-of-forex-changes-on-cash

-54.05-0.915.51.4
-0.2
-0.7
-1.1
0.5
2.3
4
-1.5
17.2
4.7
14
3.2
0.7
8.8
6.4
2.1

cash-flows.row.net-change-in-cash

76.61-65.3990.6717.3
1303.4
549.9
-40.5
373.2
253.1
-14.2
-244.4
-164.4
57.8
-226.8
788.4
-34.1
17.1
63.2
35.4

cash-flows.row.cash-at-end-of-period

2449.494311.14376.43385.7
2668.4
1365
815.1
855.6
482.5
229.3
243.5
485
668.9
615.3
888.7
103.2
137.2
128.6
69.8

cash-flows.row.cash-at-beginning-of-period

2372.884376.43385.72668.4
1365
815.1
855.6
482.5
229.3
243.5
487.9
649.4
611.1
842.1
100.2
137.2
120.1
65.4
34.4

cash-flows.row.operating-cash-flow

911.722502.93553.22493.9
2692
2555.1
1754.6
2071.8
1067.9
614.6
843.2
327.7
435.6
394.3
74.2
106.2
69.4
48
62.3

cash-flows.row.capital-expenditure

-119.26-318-524.9-184.8
-341.4
-340.5
-62
-76.6
-1073.8
-580.6
-261.5
-144.6
-68.6
-86.7
-24.9
-1.9
-7.6
-5.8
-8.8

cash-flows.row.free-cash-flow

792.462184.93028.32309
2350.6
2214.6
1692.6
1995.2
-5.9
33.9
581.7
183.1
367
307.6
49.4
104.3
61.9
42.2
53.5

Income Statement Row

China Medical System Holdings Limited's revenue saw a change of -0.124% compared with the previous period. The gross profit of CHSYF is reported to be 6109.17. The company's operating expenses are 3277.49, showing a change of -3.327% from the last year. The expenses for depreciation and amortization are 229.56, which is a 0.010% change from the last accounting period. Operating expenses are reported to be 3277.49, which shows a -3.327% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -0.086% year-over-year growth. The operating income is 3311.7, which shows a -0.086% change when compared to the previous year. The change in the net income is -0.263%. The net income for the last year was 2400.94.

common:word.in-mln

USD
Growth
TTM202320222021202020192018201720162015201420132012201120102009200820072006

income-statement-row.row.total-revenue

17163.638013.39150.38337.2
6946
6073.6
5433.4
5348.8
4900.8
3553.4
2945.1
2201.4
1759.4
1322.3
876.7
658.6
495.4
378
293.5

income-statement-row.row.cost-of-revenue

4051.831904.12114.52090.3
1811.7
1527.3
1516.6
1870.5
1988.9
1507.3
1290.5
1001
724.4
573.6
358.7
243
189.9
132.6
91.3

income-statement-row.row.gross-profit

13111.86109.27035.86246.9
5134.2
4546.3
3916.9
3478.3
2911.9
2046.1
1654.6
1200.4
1034.9
748.7
518
415.5
305.5
245.4
202.3

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

320.56---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

1293.24---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

5232.65---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-6.5-7.51.6
-1.8
1
1.5
-3.9
3.7
1.5
-3.2
5.5
3.7
50.6
0
0
0
0
0

income-statement-row.row.operating-expenses

6662.453277.53390.33030.8
2324
2143.1
1904.6
1577.6
1370.1
977.8
747.7
577.3
464
366.4
285.3
234
190
176.9
159.2

income-statement-row.row.cost-and-expenses

10714.285181.65504.85121.1
4135.8
3670.4
3421.1
3448.2
3359.1
2485.1
2038.2
1578.3
1188.4
940.1
644
477.1
380
309.5
250.5

income-statement-row.row.interest-income

187.27146.5105.581.9
61
42
26.1
17.7
20
10
35
38.9
31.8
0
0
2.2
1.6
1.9
0.2

income-statement-row.row.interest-expense

046.349.128.3
27.5
56.3
71.9
82.3
42.5
24.1
16.7
16.5
12.5
5.9
4.1
2.7
1.5
2.2
0.8

income-statement-row.row.selling-and-marketing-expenses

5232.65---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

371.28-437.9140.479
-97.7
-54
-56.9
-82.3
-62.8
-25.2
-19.1
-18.3
-12.6
-5.9
-4.1
2.4
10.1
-0.1
-0.8

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-6.5-7.51.6
-1.8
1
1.5
-3.9
3.7
1.5
-3.2
5.5
3.7
50.6
0
0
0
0
0

income-statement-row.row.total-operating-expenses

371.28-437.9140.479
-97.7
-54
-56.9
-82.3
-62.8
-25.2
-19.1
-18.3
-12.6
-5.9
-4.1
2.4
10.1
-0.1
-0.8

income-statement-row.row.interest-expense

046.349.128.3
27.5
56.3
71.9
82.3
42.5
24.1
16.7
16.5
12.5
5.9
4.1
2.7
1.5
2.2
0.8

income-statement-row.row.depreciation-and-amortization

418.38229.6227.2219.8
208.3
204.1
199
196.4
175.9
77.8
42.4
35.8
32.5
26.1
10.4
13.7
10.7
5.1
3.8

income-statement-row.row.ebitda-caps

6683.72---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

6265.343311.73622.43377.6
2913.8
2541.7
2063.2
1890.7
1563.3
1089.2
1148.6
689.5
602.4
433.8
233.8
181.5
123.2
75.7
42.8

income-statement-row.row.income-before-tax

6636.622873.83762.83456.6
2816.1
2487.7
2006.4
1808.4
1500.4
1064.1
1129.5
671.2
589.7
427.9
229.7
183.9
133.3
75.6
42

income-statement-row.row.income-tax-expense

976489.3486.7431.3
260.4
532
161.8
138.5
122.5
67.6
86.5
48.9
58.4
36
26.2
41.6
30.6
12.2
11.2

income-statement-row.row.net-income

5659.932400.932593017.4
2530.4
1960.7
1849.9
1674.8
1375.9
995.9
1045.7
623.1
530.8
391.4
202.9
141.2
102
63.4
31.3

Frequently Asked Question

What is China Medical System Holdings Limited (CHSYF) total assets?

China Medical System Holdings Limited (CHSYF) total assets is 17730837000.000.

What is enterprise annual revenue?

The annual revenue is 8013285000.000.

What is firm profit margin?

Firm profit margin is 0.758.

What is company free cash flow?

The free cash flow is 0.141.

What is enterprise net profit margin?

The net profit margin is 0.300.

What is firm total revenue?

The total revenue is 0.339.

What is China Medical System Holdings Limited (CHSYF) net profit (net income)?

The net profit (net income) is 2400940000.000.

What is firm total debt?

The total debt is 1301737000.000.

What is operating expences number?

The operating expences are 3277487000.000.

What is company cash figure?

Enretprise cash is 4311058000.000.